Inventor
Xun GUI
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes22%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
C07KPeptides22%
G01NInvestigating or analysing materials by determining their chemical or physical properties17%
C12NMicroorganisms or enzymes13%
C12YEnzymes4%
PatentTitleYear
12,570,710Targeting LILRB4 with CAR-T or CAR-NK cells in the treatment of cancer202612,202,895LILRB4 antibodies and uses thereof202511,906,519Methods for identifying LILRB-blocking antibodies202411,498,963Anti-LILRB antibodies and their use in detecting and treating cancer202211,377,491Anti-leukocyte-associated immunoglobulin-like receptor 1 (LAIR1) monoclonal antibodies and method of use thereof to treat cancer2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to UNIV TEXAS (5)· patent assignee history
2022–2026Based in US· patent location history
2025Patents assigned to IMMUNE ONC THERAPEUTICS INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV TEXAS | 5 | 2022–2026 |
| IMMUNE ONC THERAPEUTICS INC | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2022–2026 |